Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023

Stock Price vs Company Growth
1d
0.3%
1w
6.4%
1m
1.8%
3m
7.2%
6m
1.4%
1y
22.8%
all
33.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

2,568 0.3%
2,116
2,632
Company Overview

Sales
11,641 Cr
Growth: 14.8%
Profit after Tax
2,041 Cr
Growth: -3.5%
Large Cap
1,05,963 Cr
P/E: 50.5x
Industry P/E: 32.4x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 11,641
Growth 14.8%
EBITDA 25.4%
P/S 9.1x
Dividend 0.0%
P/E 50.5x
Book Value ₹ 265
PEG Ratio 3.4x
ROE 20.0%
P/B 9.7x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Followers (2)